Business Context and Reporting Period
This Form 8-K, dated January 9, 2026, reports the consummation of the initial public offering (IPO) by Black Spade Acquisition III Co, a Cayman Islands-based special purpose acquisition company (SPAC). The IPO closed on January 7, 2026, with related definitive agreements executed on January 5, 2026.
Key Financial Metrics
- IPO Gross Proceeds: $172,500,000 from the sale of 17,250,000 Units at $10.00 per unit (including 2,250,000 units from the full exercise of the underwriters' over-allotment option).
- Private Placement Proceeds: $4,075,000 total from the sale of 8,150,000 Private Placement Warrants at $0.50 per warrant ($3,500,000 to the Sponsor and $575,000 to Underwriters).
- Trust Account Funding: $172,500,000 deposited into a U.S.-based trust account, comprising $170,663,000 of net IPO proceeds and $1,837,000 of private placement proceeds.
- Warrant Exercise Price: $11.50 per share for public warrants; Private Placement Warrants are non-redeemable and may be exercisable on a cashless basis.
- Operating Metrics: The filing does not provide revenue, profit, cash flow, or margin data as the company is a pre-business combination SPAC.
Material Changes
This filing represents the company's initial public listing and capital formation. There is no prior comparable period for financial performance as the entity was formed specifically for this offering. The primary material change is the transition from a private entity to a public company with $172.5 million in gross capital raised and a new board of directors appointed.
Guidance, Outlook, and Risks
- Outlook: The company intends to consummate an initial business combination. The trust account holds funds for the benefit of public shareholders pending this combination.
- Lock-Up Periods: Private Placement Warrants held by the Sponsor are restricted from transfer until 30 days after the initial business combination. Underwriters' Private Placement Warrants are subject to a 180-day lock-up period ending January 4, 2026, and cannot be exercised for five years from the commencement of sales.
- Risks: Standard SPAC risks apply, including the ability to complete a business combination within the required timeframe and the potential for warrant redemption or expiration.
- Management Commentary: The filing confirms the appointment of four independent directors (Russell Galbut, Robert Moore, Patsy Chan, and Sammy Hsieh) and the establishment of audit, nominating, and compensation committees.
Investor Verification Checklist
- Verify the exact amount of net proceeds remaining in the trust account after deducting underwriting discounts and offering expenses.
- Confirm the specific terms of the over-allotment option exercise and its impact on the total share count.
- Review the Amended and Restated Memorandum and Articles of Association (Exhibit 3.1) for redemption rights and liquidation preferences.
- Check the status of the 180-day lock-up period for Underwriters' Private Placement Warrants and the 30-day post-combination restriction for Sponsor warrants.
- Validate the identity and independence of the newly appointed board members and their committee assignments.